טוען...
Exploratory study of (18)F-fluciclovine pet/ct for response assessment to docetaxel in patients with metastatic castration-resistant prostate cancer
Monitoring therapeutic response in patients with metastatic castration-resistant prostate cancer (mCRPC) can be challenging. We set out to determine if (18)F-fluciclovine PET/CT could be a useful imaging biomarker for response to docetaxel chemotherapy in patients with mCRPC. Seven patients with mCR...
שמור ב:
| הוצא לאור ב: | Am J Nucl Med Mol Imaging |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
e-Century Publishing Corporation
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8255212/ https://ncbi.nlm.nih.gov/pubmed/34235000 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|